Man Survives 100 Days with Artificial Titanium Heart in Groundbreaking Medical Trial
A groundbreaking medical trial in Australia has seen a man survive for 100 days with an artificial titanium heart, marking a significant milestone in cardiac technology.
The patient, a man in his 40s who has chosen to remain anonymous, received the BiVACOR Total Artificial Heart (TAH) in November at St. Vincent's Hospital Sydney. In February, he became the first person to be discharged from the hospital while relying on the device. Earlier this month, he successfully underwent a donor heart transplant and is now recovering well, according to a joint statement from St Vincent's Hospital, Monash University, and BiVACOR, the company behind the artificial heart.
The BiVACOR TAH is designed to replace both ventricles of a failing heart. It features a single moving part—a magnetically levitated rotor—constructed from titanium, eliminating the need for mechanical bearings or valves that could wear out over time.
Australian bioengineer Daniel Timms, who founded BiVACOR after losing his father to heart disease, called the achievement a major step forward in heart failure treatment. "This milestone represents decades of hard work, and we are deeply grateful to the patient and his family for trusting our technology," Timms said.
Professor Chris Hayward of the Victor Chang Cardiac Research Institute, who has been overseeing the patient's recovery, said the success of the device could transform the future of heart transplants. "Within the next decade, artificial hearts may become a viable alternative for patients who are unable to receive donor hearts in time," Hayward stated.
The BiVACOR device has been undergoing trials in the United States as part of the FDA's Early Feasibility Study. Five patients have been implanted with the device so far, including a 58-year-old man in Texas last year, who survived for eight days before receiving a donor heart. Researchers hope the study will expand to 15 patients.
The Australian trial is part of Monash University's Artificial Heart Frontiers Program, a AU$50 million ($31 million) initiative aimed at advancing artificial heart technology.
Cardiovascular disease remains the leading cause of death worldwide, with around 18 million fatalities annually, according to the World Health Organization. Experts believe that artificial hearts like the BiVACOR TAH could help address the shortage of donor hearts and improve survival rates for patients with end-stage heart failure.
Medical researchers say further trials will be needed before the BiVACOR heart can be considered for widespread use, but this latest development marks a promising step forward in the field of cardiac care.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Tribune
23-05-2025
- Daily Tribune
22,000+ Surgeries and 7,600+ Births: Bahrain Hospitals in High Gear
Dr. Mariam Athbi Al Jalahma, Chief Executive Officer of Government Hospitals, reaffirmed the institution's commitment to advancing healthcare services and optimizing available resources to support the health sector and serve the community. Her remarks came during a tour with editors-in-chief of local newspapers, aimed at highlighting key achievements of government hospitals in 2024. Dr. Al Jalahma praised the vital role played by the national press as an active member of Team Bahrain, emphasizing its contribution to showcasing national achievements across various sectors. She revealed that government hospitals have successfully implemented 80% of their self-management plan, a strategic initiative designed to enhance operational efficiency. Salmaniya Medical Complex (SMC) recorded an average bed occupancy rate of 80%, and 90% in intensive care units, reflecting the high operational capacity of these facilities. In the field of medical training and professional development, Dr. Al Jalahma reported that 46 doctors were sent abroad for specialized fellowship programs, while 304 doctors enrolled in various board certification programs. Additionally, 1,509 nurses received training across different nursing specialties, significantly boosting the competency of national medical staff. During 2024, government hospitals received over 1.2 million visits, including more than 400,000 visits to the emergency department at SMC and over 509,000 visits to outpatient clinics. Bahrainis accounted for 82% of the total patients served. The hospitals conducted more than 20.4 million laboratory tests and over 316,000 radiology exams throughout the year. In addition, 22,944 surgical operations and 7,670 childbirth cases were recorded, highlighting the institutions' critical role in providing daily healthcare services. To expand service capacity, 56 additional beds were made operational, along with specialized units such as a short-stay unit for women with sickle cell anemia and a biological treatment unit. A dedicated psychiatric emergency wing was also introduced, signaling a move toward more specialized and integrated health services. Government hospitals earned several national and international accreditations in 2024. Notably, SMC was designated as an official examination center for the UK's Royal College of Physicians fellowship exams. The institution also secured Australian accreditation, ISO certification for its laboratory, and national accreditation from the National Health Regulatory Authority (NHRA) with a platinum rating. Additionally, it received institutional accreditation from the Saudi Commission for Health Specialties and won three patient safety awards from the Arab Hospitals Federation. As part of Bahrain's initiative to modernize 500 government services, 23 new e-services were launched. These included services related to sick leave documentation, medical report requests, appointment changes, and remote consultation clinics at correctional and rehabilitation centers. On the performance improvement front, 145 development projects were implemented, 47 key performance indicators (KPIs) were monitored, and advanced mechanisms for risk management and clinical auditing were introduced. The hospitals also inaugurated a strategic planning and project management department, along with a digital dashboard to track KPIs—steps aimed at bolstering institutional efficiency and oversight. These advancements underscore the continued evolution of government healthcare in Bahrain, reinforcing its commitment to delivering high-quality, patient-centered care aligned with national development goals.
Daily Tribune
14-03-2025
- Daily Tribune
Man Survives 100 Days with Artificial Titanium Heart in Groundbreaking Medical Trial
A groundbreaking medical trial in Australia has seen a man survive for 100 days with an artificial titanium heart, marking a significant milestone in cardiac technology. The patient, a man in his 40s who has chosen to remain anonymous, received the BiVACOR Total Artificial Heart (TAH) in November at St. Vincent's Hospital Sydney. In February, he became the first person to be discharged from the hospital while relying on the device. Earlier this month, he successfully underwent a donor heart transplant and is now recovering well, according to a joint statement from St Vincent's Hospital, Monash University, and BiVACOR, the company behind the artificial heart. The BiVACOR TAH is designed to replace both ventricles of a failing heart. It features a single moving part—a magnetically levitated rotor—constructed from titanium, eliminating the need for mechanical bearings or valves that could wear out over time. Australian bioengineer Daniel Timms, who founded BiVACOR after losing his father to heart disease, called the achievement a major step forward in heart failure treatment. "This milestone represents decades of hard work, and we are deeply grateful to the patient and his family for trusting our technology," Timms said. Professor Chris Hayward of the Victor Chang Cardiac Research Institute, who has been overseeing the patient's recovery, said the success of the device could transform the future of heart transplants. "Within the next decade, artificial hearts may become a viable alternative for patients who are unable to receive donor hearts in time," Hayward stated. The BiVACOR device has been undergoing trials in the United States as part of the FDA's Early Feasibility Study. Five patients have been implanted with the device so far, including a 58-year-old man in Texas last year, who survived for eight days before receiving a donor heart. Researchers hope the study will expand to 15 patients. The Australian trial is part of Monash University's Artificial Heart Frontiers Program, a AU$50 million ($31 million) initiative aimed at advancing artificial heart technology. Cardiovascular disease remains the leading cause of death worldwide, with around 18 million fatalities annually, according to the World Health Organization. Experts believe that artificial hearts like the BiVACOR TAH could help address the shortage of donor hearts and improve survival rates for patients with end-stage heart failure. Medical researchers say further trials will be needed before the BiVACOR heart can be considered for widespread use, but this latest development marks a promising step forward in the field of cardiac care.
Daily Tribune
11-01-2025
- Daily Tribune
Djokovic alleges poisoning in 2022 detention
Novak Djokovich as claimed that he was 'poisoned' by lead and mercury in his food while he was briefly held in Melbourne in 2022 before being deported on the eve of the Australian Open. The former world number one had his visa cancelled and was eventually kicked out of the country over his refusal to be vaccinated against Covid. He was held in a detention hotel as he fought a fruitless legal battle to remain. 'I had some health issues. And I realised that in that hotel in Melbourne I was fed some food that poisoned me,' the 37-yearold Djokovic told GQ magazine in a lengthy interview published Thursday. 'I had some discoveries when I came back to Serbia. I never told this to anybody publicly, but discoveries that I had a really high level of heavy metal. I had lead, a very high level of lead and mercury.' When asked if he believed his food was contaminated, the Serb replied: 'That's the only way.' A spokesperson for Australia's Department of Home Affairs said it could not comment on individual cases 'for privacy reasons'. But the government says a lease agreement with the Park Hotel where he was held provides for freshly cooked, individually portioned lunches and dinners for detainees. Nutritious All catering st a f f h ave undertaken food safety certifications , it says. And, as of December 31, 2021, the hotel had been providing samples of the food provided to detainees at each meal to the contractor responsible for detention services. Australia says detainees had access to a variety of food and drink that was nutritious, culturally appropriate and satisfied specific medical or dietary requirements. They were also offered breakfast items such as bread, cereal, noodles, tea and coffee at any time of the day or night. Djokovic will be bidding for an 11th Australian Open title and a record-setting 25th major when the season's first Grand Slam event gets underway on Sunday. He insists that he does not hold 'any grudge over the Australian people' despite the 2022 controversy. A year later, he returned to Melbourne where he swept to the title. 'A lot of Australian people that I meet in Australia the last few years or elsewhere in the world, have come up to me, apologising to me for the treatment I received because they were embarrassed by their own government at that point,' he said. 'And I think the government's changed, and they reinstated my visa, and I was very grateful for that. 'I actually love being there, and I think my results are a testament to my sensation of playing tennis and just being in that country.' However, he added: 'Never met the people that deported me from that country a few years ago. I don't have a desire to meet with them. If I do one day, that's fine as well. I'm happy to shake hands and move on.'
